Results: NRs were identified in 40% of unilateral WTs, including 25% perilobar nephrogenic rest (PLNR), 9% intralobar nephrogenic rest (ILNR), 5% both PLNR and ILNR, and 1% nephroblastomatosis, and in 93% of cases with bilateral lesions. ILNRs were associated with stromal histology and a younger age at diagnosis and found frequently in patients with congenital anomalies associated with WT1 mutation. PLNRs were found frequently in patients with overgrowth syndromes.
INTRODUCTION
Nephrogenic rests (NRs) are regarded as precursor lesions of Wilms tumor (WT) and have been defined as "foci of abnormally persistent nephrogenic cells, retaining cells that can be induced to form a Wilms tumor." 1, 2 Rests are subdivided into two main types: perilobar nephrogenic rest (PLNR), confined to the periphery of the renal lobe, and intralobar nephrogenic rest (ILNR), found anywhere within the renal lobe. 2, 3 Nephroblastomatosis (NBL) is defined as the "diffuse or multifocal presence of NRs or their recognized derivatives." 2 They can be further subclassified as incipient or dormant, regressing or sclerosing, obsolescent, and hyperplastic NRs. in NRs and their associated WTs, either focusing on specific genes or using genome-wide approaches. [4] [5] [6] These have identified common genetic changes in both NRs and WTs, assumed to occur at an early stage, with later changes found only in tumors. Such studies are ongoing and aim to help identify key WT driver genes in a manner analogous to that of Vogelstein and Fearon's model for colorectal cancer. 7 To date, almost all studies of NRs come from the North American National Wilms Tumor Study (NWTS) group. The largest of these, studying 5,954 patients from NWTS3, 4, and 5 studies, identified NRs in 42% of patients with WTs (20% PLNR, 18% ILNR, and 4% PLNR and ILNR). 3 
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In the NWTS, NRs were found in 28% of the patients with unifocal tumors and in over 90% with multifocal disease. 3 The almost universal presence of NRs in bilateral WT disease is thought to reflect germline changes resulting in predisposition to WT development. 4, 8 Approximately 5-10% of children with WT have disease affecting both kidneys. 9 This may be either bilateral WT, bilateral NRs, or unilateral WT with contralateral NR(s). The distribution of NRs varies by ethnic group. Fukuzawa et al. reported PLNR rates of 8% in Asian Americans and only 2% in Japanese patients, compared to 24% in White Americans. 10 In a series of 127 WTs from India, no cases of PLNR were observed, whereas 45% had associated ILNR. 11 In contrast to the NWTS, the patients in the International Society of Pediatric Oncology (SIOP) trials undergo preoperative chemotherapy prior to nephrectomy (two drugs for 4 weeks for localized and three drugs for 6 weeks for metastatic tumors at presentation). 12 This article summarizes the patterns of NRs in the UK SIOP WT 2001 Trial.
MATERIALS AND METHODS

Patients
The SIOP WT 2001 Trial was an 11-year international multicenter study that recruited 4,763 patients with renal tumors of childhood. All pediatric patients with renal tumor at registered institutions were eligible for registration into this study. The UK study center registered patients from across all pediatric cancer primary treatment centers in the UK and Ireland (841 cases) along with a few patients from centers in New Zealand (six cases) and Australia (two cases). Full informed consent was given for all participants.
Inclusion criteria
This study included the patients who fulfilled the following criteria: The presence of congenital anomalies was recorded on the case report form at registration. These data were later reviewed and any missing data or contradictions were discussed with local centers and the study database was updated.
Histological review
As part of the study, all registered cases were sampled according to the SIOP 2001 Trial Pathology protocol 13 and submitted for central pathology review for diagnosis, classification, and staging. 12 Histological features of NRs in cases treated with preoperative chemotherapy will be described in a separate paper (in preparation).
Statistical methods
Summary statistics were used to describe the data. A chi-square test was used for comparison of proportions. A Wilcoxon-Mann-Whitney test was used to compare distributions of continuous variables. Frequency distributions for age at diagnosis were inspected using histograms with Gaussian kernel smoothing. Results were considered statistically significant at 5%, with no adjustment for multiple testing. All analyses presented are univariable, that is, not adjusted for other factors. The analysis was performed in Stata v12. 15 
RESULTS
Patients
Eight hundred forty-nine patients registered in the SIOP WT 2001 Trial in the UK. This study involved 705/849 (83%) patients who fulfilled the criteria for this analysis, including 636/705 (90%) with unilateral and 69/705 (10%) with bilateral WTs (Fig. 1 ).
Frequency of NR
NRs were identified in 318/705 (45%) of all cases, including 253/636 (40%) with unilateral and 65/69 (94%) with bilateral disease.
Unilateral disease
Out of 636 patients with unilateral WTs, 159 (25%) had PLNR, 58 (9%) ILNR, 30 (5%) combined PLNR and ILNR, and 6 (1%) NBL ( Table 2 ).
The distribution of age at diagnosis of patients with unilateral WTs by gender is shown in Table 2 and Figure 2 . Male patients had a younger age at diagnosis in all rest groups except diffuse NBL, where the numbers were very small. Patients with ILNR had a younger median age at diagnosis of 1.9 years compared with patients with no ILNR with median age of 3.4 years (P < 0.001).
There is a suggestion of a bimodal distribution of age at diagnosis of unilateral WTs in females, peaking at 2 and 4 years. While these peaks may be attributed to those tumors containing ILNR and PLNR, such a pattern is also seen in patients with no NRs (Fig. 2) .
Bilateral disease
In 65/69 (93%) patients who presented with bilateral disease, NRs were identified in one or both kidneys (Fig.3) .
Although there was a more noticeable excess of females (65%, 45/69) in patients with bilateral disease, it was not significantly different when compared to unilateral disease (P = 0.052). Patients with bilateral disease were of younger age at diagnosis compared with patients with unilateral WT alone (P < 0.001). Median age at diagnosis of patients with bilateral disease was 1.8 years, ranging from 2 months to 11 years (patients under 6 months of age were not initially treated with preoperative chemotherapy).
There were 35 histologically confirmed bilateral WTs, with a median age at diagnosis of 1.8 years. Of these, 86% (30/35) had NRs identified in one or both kidneys, including 43% (15/35) with PLNR, 20% (7/35) with ILNR, and 23% (8/35) with combined ILNR and PLNR.
Twenty-six cases had documented contralateral lesions on imagining studies with a histologically confirmed WT in the ipsilateral kidney. F I G U R E 2 Frequency distributions of age at diagnosis by gender and by rest type for patients with unilateral WT a hyperplastic PLNR was present in the fourth. In six cases, it was not possible to confirm histologically on the material available whether the lesion in one kidney was NR or WT. In all of those cases, NRs were identified in the kidney with the tumor. In the remaining six cases, no biopsy of the lesions in the contralateral kidney was done. In each of these cases, rests were identified on the side of the confirmed tumor (three PLNR, two NBL, and one PLNR and ILNR).
TA B L E 2
Of the eight patients who presented with bilateral NRs, one was a 2-month-old baby with Beckwith-Wiedemann syndrome (BWS), who was diagnosed clinically with bilateral NBL. The remaining seven cases (median age at diagnosis of 1.4 years, range 0.17-2.4 years) had biopsy on at least one side. In one case, there was progression to histologically confirmed anaplastic WT 13 months after diagnosis. Full details of this case have been described by Popov et al. 16 
Congenital anomalies and NR
Congenital anomalies were present in 12% (81/705) of patients, including 9% (58/636) with unilateral WT and 33% (23/69) with bilateral disease. The presence and type of NRs in 49 (60%) patients with specific anomalies associated with WTs are presented in Table 3 . There were a further 32 patients with a range of other abnormalities, 18
(56%) of whom had NRs (39% PLNR, 9% ILNR, 3%, both PLNR and ILNR, and 3% NBL).
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F I G U R E 3 Distribution of bilateral disease
ILNRs were identified in six of seven cases of aniridia, and all of them were associated with stromal type WT. There was one case of Denys- 
DISCUSSION
We presented the first analysis of NRs in patients with WTs treated with preoperative chemotherapy. The study of such detailed data was dependent on the centralized pathology review process built into the SIOP WT 2001 protocol and the high proportion of all nationally registered cases. The review of the complete sets of slides prepared according to the protocol in each case was in contrast to review of only a limited number of "representative" slides in previous studies. 17 This was the likely reason why NRs were found in only around 15% of cases in the previous SIOP and UK Trials (author's, GMV, personal observation, unpublished data).
The overall frequency of NRs identified in postchemotherapy specimens in this study was similar to that found in a large study of nearly 6,000 cases of primarily operated WTs in the United States (45 vs. 42%). 3 In contrast to our study, wherein WTs were classified as unilat- Table S1 ). However, it was virtually identical to another study on White American children only (24%). 10 are associated with ILNR, whereas 11p15 epimutations, such as in BWS, are associated with PLNR. 3 However, germ-line genetic data
were not analyzed as part of this work, so it is not possible to confirm the presence of WT1 gene mutations/deletions in all of these cases.
As observed previously, 3 we also found that both unilateral and bilateral tumors were more common in girls than in boys, and boys had a younger age distribution at diagnosis. However, unlike the US cohort, the current study found no excess of PLNR or deficit of ILNR among girls and the bimodal age distribution of cases among females was present even in the absence of rests. 3 This distribution may be a reflection of the two separate molecular pathways occurring even in the absence of morphologically recognizable rests. 3 In contrast to patients with ILNRs, those with PLNRs were older at diagnosis. Furthermore, PLNRs were seen in the majority of patients with BWS and/or HH, as observed in the US cohorts. 1, 3 Together, these data support the previous suggestions of at least two pathways to WT development, so called "type I," characterized by a young age at diagnosis, presence of ILNRs and stromal histology, likely involving WT1 mutations, and "type 2," associated with an older age at diagnosis, PLNR and nonstromal histology, likely involving deregulation of IGF2. 3 The younger age of onset in males in our and other studies also suggests that there may also be differences in pathological mechanisms between genders, perhaps either related to critical genes being on the sex chromosomes themselves or a differing impact of mutations in genes determining urogenital development according to the embryonic environment in the two sexes. 3 NRs were present in 94% of the cases of bilateral disease, which is consistent with Beckwith's observation of the presence of rests in almost all cases of bilateral disease. 1 In the NWTS, NRs were found in 90% of multifocal WTs. 3 This observation supports the concept that in bilateral disease a mutation or epimutation in the germline, or very early in development, results in an underlying predisposition to rest and consequently to tumor development.
The difficulty in histologically definitively distinguishing NRs from WT in some cases, even by highly experienced specialist review pathologists, as seen in one unilateral and six bilateral lesions, was also previously been observed to occur in only 1.2% of patients with unilateral WT, and the presence of NR is recognized as a risk factor for this. 19 Both ILNR and PLNR, particularly when hyperplastic, have been linked with the development of metachronous tumors, but numbers in this series were small and so no further correlation is possible. 1, [19] [20] [21] Development of metachronous tumors after chemotherapy and/or surgical removal of NRs in the remaining kidney is well-recognised, 21 but better understanding of the molecular pathology underlying the fates of rest may help in further understanding the progression.
CONCLUSION
Our study showed no observed difference on the overall prevalence of NRs (318/705 = 45%) compared the NWTS (2,494/5,954 = 42%), except for ILNRs, which were not found as frequently as in the NWTS. We cannot conclude that the difference is due to preoperative chemotherapy due to potential difference in patients' characteristics.
ILNRs were associated with stromal type WT and younger age, offering further support to the belief that there are at least two separate pathways of Wilms tumorigenesis, whereby WT1 pathway mutations lead to ILNR and stromal type WTs and IGF2 pathway changes result in PLNR and other nonstromal histological subtypes. 3, 22, 23 Congenital anomalies were present in 12% of the patients, including 9% of patients with unilateral WT and 33% with bilateral disease. In patients with congenital anomalies, NRs were found in 60% of the cases.
Further integration of detailed histopathologic information with molecular and genetic information of patient's tumors, rests and germline and the radiologic images of tumors and NRs has the potential to support some of the difficult clinical decisions, particularly regarding management of bilateral disease.
